Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  241 results for ""Antirheumatic Agents""

Your Filters

Geographic : sweden
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Genome-wide investigation of persistence with methotrexate treatment in early rheumatoid arthritis.

  • Authors : Sysojev AÖ; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institute, Stockholm, Sweden.; Saevarsdottir S

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/genetics ; Methotrexate*/Methotrexate*/Methotrexate*/therapeutic use

  • Source: Rheumatology (Oxford, England) [Rheumatology (Oxford)] 2024 May 02; Vol. 63 (5), pp. 1221-1229.Publisher: Oxford University Press Country of Publication: England NLM ID: 100883501 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The serological immunogenicity of the third and fourth doses of COVID-19 vaccine in patients with inflammatory rheumatic diseases on different biologic or targeted DMARDs: a Swedish nationwide study (COVID-19-REUMA).

  • Authors : Frodlund M; Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, Linköping, Sweden.; Nived P

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Rheumatic Fever*SARS-CoV-2 variants

  • Source: Microbiology spectrum [Microbiol Spectr] 2024 Apr 02; Vol. 12 (4), pp. e0298123. Date of Electronic Publication: 2024 Mar 05.Publisher: ASM Press Country of Publication: United States NLM ID: 101634614 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comorbidities and chance of remission in patients with early rheumatoid arthritis receiving methotrexate as first-line therapy: a Swedish observational nationwide study.

  • Authors : Tidblad L; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden .; Westerlind H

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/epidemiology

  • Source: RMD open [RMD Open] 2023 Dec 20; Vol. 9 (4). Date of Electronic Publication: 2023 Dec 20.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Comparative cardiovascular safety with janus kinase inhibitors and biological disease-modifying antirheumatic drugs as used in clinical practice: an observational cohort study from Sweden in patients with rheumatoid arthritis.

  • Authors : Bower H; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden .; Frisell T

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/epidemiology

  • Source: RMD open [RMD Open] 2023 Nov 23; Vol. 9 (4). Date of Electronic Publication: 2023 Nov 23.Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

How does current disease activity in rheumatoid arthritis affect the short-term risk of acute coronary syndrome? A clinical register based study from Sweden and Norway.

  • Authors : Delcoigne B; Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden. Electronic address: .; Provan SA

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/epidemiology ; Acute Coronary Syndrome*/Acute Coronary Syndrome*/Acute Coronary Syndrome*/complications

  • Source: European journal of internal medicine [Eur J Intern Med] 2023 Sep; Vol. 115, pp. 55-61. Date of Electronic Publication: 2023 Jun 22.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9003220 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Remission, response, retention and persistence to treatment with disease-modifying agents in patients with rheumatoid arthritis: a study of harmonised Swedish, Danish and Norwegian cohorts.

  • Authors : Westerlind H; Clinical Epidemiology Division, Department of Medicine, Solna, Karolinska Institutet, Stockholm, Sweden .; Glintborg B

Subjects: Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/diagnosis ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/epidemiology

  • Source: RMD open [RMD Open] 2023 Sep; Vol. 9 (3).Publisher: BMJ Publishing Group Country of Publication: England NLM ID: 101662038 Publication Model: Print Cited Medium: Internet ISSN: 2056-5933

Record details

Read More Add to Saved list
×
Academic Journal

Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice: results from the ARTIS programme.

Subjects: Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/adverse effects ; Biological Products*/Biological Products*/Biological Products*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 May; Vol. 82 (5), pp. 601-610. Date of Electronic Publication: 2023 Feb 14.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

Read More Add to Saved list
×
Academic Journal

The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017.

  • Authors : Exarchou S; S. Exarchou, MD, PhD, Department of Clinical Sciences Malmö, Rheumatology, Lund University, Malmö; .

Subjects: Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/diagnosis ; Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/drug therapy ; Arthritis, Psoriatic*/Arthritis, Psoriatic*/Arthritis, Psoriatic*/epidemiology

  • Source: The Journal of rheumatology [J Rheumatol] 2023 Jun; Vol. 50 (6), pp. 781-788. Date of Electronic Publication: 2023 Mar 01.Publisher: Journal Of Rheumatology Publishing Co Country of Publication: Canada NLM ID: 7501984 Publication Model: Print-Electronic Cited Medium:

Record details

Read More Add to Saved list
×
Academic Journal

The impact of immunomodulating treatment on the immunogenicity of COVID-19 vaccines in patients with immune-mediated inflammatory rheumatic diseases compared to healthy controls. A Swedish nationwide study (COVID19-REUMA).

  • Authors : Frodlund M; Department of Biomedical and Clinical Sciences, Division of Inflammation and Infection/Rheumatology, Linköping University, Linköping, Sweden.; Nived P

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; Antirheumatic Agents*/Antirheumatic Agents*/Antirheumatic Agents*/therapeutic use ; Rheumatic Diseases*/Rheumatic Diseases*/Rheumatic Diseases*/drug therapy

  • Source: Vaccine [Vaccine] 2023 May 11; Vol. 41 (20), pp. 3247-3257. Date of Electronic Publication: 2023 Apr 04.Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 8406899 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Venous thromboembolism with JAK inhibitors and other immune-modulatory drugs: a Swedish comparative safety study among patients with rheumatoid arthritis.

Subjects: Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/epidemiology ; Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/Janus Kinase Inhibitors*/therapeutic use ; Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/Arthritis, Rheumatoid*/drug therapy

  • Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2023 Feb; Vol. 82 (2), pp. 189-197. Date of Electronic Publication: 2022 Sep 23.Publisher: BMJ Country of Publication: England NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060

Record details

Read More Add to Saved list
×
  • 1-10 of  241 results for ""Antirheumatic Agents""